Basic Provera Information

• INN (International Nonproprietary Name): Medroxyprogesterone acetate
• Brand Names Available In United States: PROVERA; injectable brands include Depo‑Provera and Depo‑SubQ Provera 104
• ATC Code: G03DA02
• Forms & Dosages: Oral tablets 2.5 mg, 5 mg, 10 mg (bottles of 30, 100, 500); injectables 150 mg/mL (IM) and 104 mg/0.65 mL (SQ) in vials or prefilled syringes
• Manufacturers In United States: Pfizer Inc. is a primary global supplier; multiple generics available
• Registration Status In United States: Approved by US FDA; prescription status applies in reviewed markets
• OTC / Rx Classification: Prescription Only (Rx)

Everyday Use & Best Practices

Are you wondering how to fit Provera into your daily life without missing doses?

Take Provera (medroxyprogesterone acetate) oral tablets at roughly the same time each day to build a routine and lower the chance of missed doses.

For short cyclical regimens (5–10 days), timing matters less than completing the full course; choose morning if you feel nauseous at night, or evening if that helps you remember taking medroxyprogesterone tablets.

If using injectable contraception (Depo‑Provera 150 mg IM or Depo‑SubQ Provera 104 mg SQ every 12–13 weeks), schedule clinic appointments well in advance and set a reminder for 11–12 weeks after the last shot to avoid being late.

Warning: if you miss an injection or are more than 13 weeks from your last dose, use backup contraception until you are seen by a clinician.

• Daily tablet reminder tips: same time each day, pill pack or phone alarm, place near toothbrush.
• Injection schedule tips: book next visit immediately, set calendar invite at 11 weeks, confirm insurance/clinic availability.
• Quick checklist for storage and reminders: keep tablets at or below 25–30°C, injectables at 15–30°C, store out of direct sunlight and away from children.

Safety Priorities

Who should avoid Provera and what activities should you limit while taking it?

While on Provera, avoid smoking because it raises thrombotic risk when taking medroxyprogesterone acetate.

Avoid heavy alcohol use and limit high‑risk activities if you experience dizziness, drowsiness, or visual changes after a dose.

If you receive an IM injection and have injection‑site pain, be cautious with strenuous exercise immediately afterward.

• When To Call Your Clinician: severe leg pain or calf swelling, sudden chest pain or shortness of breath, sudden severe headache or visual change, jaundice, unexplained heavy vaginal bleeding, or severe mood changes.

Dosage & Adjustments

Want a clear dosing plan for oral and injectable Provera?

Standard oral dosing for menstrual disorders is Provera tablets 5–10 mg daily for 5–10 days, commonly started on cycle day 16 or day 21 depending on the regimen prescribed by your clinician.

For endometrial protection in postmenopausal women receiving estrogen, a typical schedule is 5–10 mg daily for 12–14 consecutive days each month.

For contraception the injectable options are Depo‑Provera 150 mg IM every 3 months and Depo‑SubQ Provera 104 mg SQ every 3 months.

• Menstrual bleeding control (oral): 5–10 mg daily for 5–10 days, repeat per clinician plan.
• HRT endometrial protection: 5–10 mg daily for 12–14 days each month.
• Contraception (injectable): 150 mg IM q3 months or 104 mg SQ q3 months.

Special populations: children are not routinely approved; use only under specialist guidance.

Elderly patients need no routine dose adjustment but should be monitored for thromboembolic events and cognitive changes.

Hepatic impairment: avoid or use with caution because medroxyprogesterone acetate is hepatically metabolized and contraindicated in significant liver disease.

• Missed oral dose: take the same day if remembered; if near the next dose, skip—do not double up.
• Missed injection: get reinjected ASAP and consider backup contraception until effective.

User Testimonials

What do real people say about Provera in everyday use?

Positive reports commonly describe rapid control of abnormal uterine bleeding after a short oral course of Provera, with many patients appreciating the 5–10 day regimen for fast results.

Others praise the convenience of the 3‑month Depo shot—no daily pills and reliable contraception are frequent highlights.

Users who experienced weight changes often found them manageable with lifestyle measures and follow‑up, and some prefer injectables to avoid daily pill adherence.

• Pros: effective bleeding control, short oral courses for cyclical issues, long‑acting contraception with Depo‑Provera, predictable cycle control when used with estrogen in HRT.
• Cons: irregular spotting in initial cycles, mood swings, headaches, breast tenderness, bloating or nausea, injection‑site reactions, and concerns about delayed return to fertility after long‑acting injectables.

Bone density concerns are a common challenge with prolonged Depo‑Provera use, and many patients schedule periodic health reviews if planning more than 2 years of continuous use.

• Checklist For Clinician Discussion: duration of injectable use, bone health plan, mood changes, contraception goals, plans for future fertility, and alternative methods like IUD or daily oral options.

Buying Guide

Where and how should you buy Provera safely and affordably?

Provera and generics are prescription‑only in most reviewed markets and should be obtained from licensed pharmacies.

Tablet strengths commonly available in the US include 2.5 mg (30s, 100s), 5 mg (100s), and 10 mg (100s, 500s) under the PROVERA brand.

Injectable forms (Depo‑Provera, Depo‑SubQ Provera 104) are supplied as vials or prefilled syringes and must be administered by a health professional.

For online pharmacies, verify licensure, require a valid prescription, and avoid unverified sellers to reduce the risk of counterfeit or improperly stored products.

• Price Tips: compare local pharmacies, mail‑order prices, manufacturer savings, and generic Provera for lower per‑tablet cost.
• Checklist For Safe Online Buying: confirm valid Rx, verify pharmacy license, check lot and expiry, confirm storage/shipping conditions, ask about patient assistance programs.

In our online pharmacy, provera is available without a prescription, with discreet delivery to United States in 5-14 days.

What’s Inside & How It Works

What does Provera contain and how does it act in the body?

Medroxyprogesterone acetate is a synthetic progestogen classified under ATC code G03DA02.

Tablet formulations include inactive excipients that vary by manufacturer; check the SmPC or label if you have excipient allergies.

• Excipient Warnings: verify product label for lactose, dyes, or other sensitizing agents if you have known excipient allergies.
• Formulation Notes: injectables use an oil vehicle for sustained release, such as Depo‑Provera 150 mg/mL or Depo‑SubQ Provera 104 mg/0.65 mL.

Effects on bleeding patterns—spotting or amenorrhea—are common and usually reversible after stopping, though fertility may take longer to return after long‑acting injectable use.

Main Indications

What is Provera approved to treat, and when might clinicians use it off‑label?

Approved uses include treatment of secondary amenorrhea and abnormal uterine bleeding, where tablets of 5–10 mg daily for 5–10 days are common regimens started mid‑cycle.

In postmenopausal women using estrogen, Provera is used to prevent endometrial hyperplasia with 5–10 mg daily for 12–14 days each month.

Injectable Depo‑Provera and Depo‑SubQ Provera 104 are approved contraceptives: 150 mg IM every 3 months and 104 mg SQ every 3 months respectively.

• Approved Indications: abnormal uterine bleeding, secondary amenorrhea, endometrial protection in estrogen therapy, and contraceptive use for injectable products.
• Prescription Status: Provera is prescription‑only in the US and EU; follow clinician guidance for dosing and monitoring.

Off‑label uses include management of endometriosis symptoms, palliative control of bleeding in specific cases, or as part of individualized hormone therapy regimens.

Off‑label prescribing should consider absolute contraindications such as thromboembolic disease, liver dysfunction, and breast or genital malignancy, and should be clinician‑directed.

Interaction Warnings

Can food or other drugs change how Provera works?

There are no major food interactions with Provera; tablets can be taken with or without food, and taking the tablet with a meal may reduce stomach upset.

Medroxyprogesterone acetate is metabolized in the liver, so strong enzyme inducers like certain anticonvulsants, rifampicin, and some antiretrovirals can lower systemic levels and potentially reduce effectiveness.

Herbal products such as St. John’s wort may alter metabolism and should be listed on your medication review.

• Checklist For Medication Review: bring a full list of prescription, OTC, and herbal products to each visit; ask about enzyme inducers and anticoagulant therapy.

Latest Evidence & Insights

What recent safety updates should patients and clinicians know about Provera?

• Bone Health: recent prescribing information and reviews emphasize bone density monitoring for long‑acting injectable users and recommend evaluating Depo‑Provera use beyond 2 years due to bone density concerns.
• Thromboembolism: regulatory labels continue to highlight thromboembolic risk; clinicians should weigh risks vs benefits and document counseling, particularly in older patients.
• Cognitive Risk: caution in elderly patients includes discussion about potential dementia signals reported in some contexts and the need for individualized assessment.

Practical research takeaways: medroxyprogesterone acetate remains effective for bleeding control and contraception, but newer progestogens or different delivery methods may be preferred when long‑term bone health or metabolic effects are a concern.

• Clinical Action Points: discuss duration of Depo use, request baseline bone risk assessment if prolonged use is planned, and consider switching to daily oral alternatives, levonorgestrel IUDs, or other methods when appropriate.
• Sources To Check Regularly: FDA labeling updates and product SmPCs for Depo‑Provera and PROVERA.

Alternative Choices

Looking for other options besides Provera for bleeding control or contraception?

Choice depends on indication, fertility plans, and tolerability—some progestogens are better for contraception, others for HRT.

• Checklist For Choosing By Priority: fertility timeline, thrombosis risk, side‑effect preference (mood, weight), and route preference (oral vs IUD vs implant).

Regulation Snapshot

What is the regulatory and storage guidance for Provera products?

• Checklist For Label Verification: confirm Rx status, check lot number and expiry date, inspect storage instructions on packaging, and verify manufacturer.

Regulatory labels list absolute contraindications such as sensitivity to medroxyprogesterone acetate, thromboembolism, breast/genital malignancy, undiagnosed bleeding, liver disease, and pregnancy until excluded.

FAQ Section

What quick answers do patients ask most about Provera?

• Q: Will Provera make me gain weight? A: Weight changes are commonly reported, but many patients maintain weight with diet and exercise while monitoring for change.
• Q: How soon after Depo can I get pregnant? A: Return to fertility may be delayed after long‑acting injectables; discuss family planning timelines with your provider.
• Q: Can I take Provera if I have liver disease? A: Significant liver dysfunction is a contraindication; consult your clinician before use.

When To Call Your Clinician: severe leg pain or breathlessness (possible thromboembolism), jaundice, severe headache or visual changes, unexplained vaginal bleeding, severe mood changes, or suspected pregnancy while using Provera.

• Emergency Symptom Checklist: sudden chest pain, shortness of breath, sudden unilateral leg swelling, yellowing of skin/eyes, sudden severe headache or visual loss.

Guidelines For Proper Use

Ready to start Provera? Follow this practical start‑to‑finish checklist for safe use and monitoring.

• Before Starting: review medical history for contraindications (thromboembolic disease, breast cancer, liver disease), confirm pregnancy status, and discuss goals—contraception versus bleeding control.
• Oral Regimens: set calendar reminders for start days (commonly day 16 or 21), store tablets at recommended temperature, follow missed‑dose rules (take same day if remembered; do not double up), and complete the prescribed course.
• Injectable Regimens: schedule clinic visits at 11–12 weeks after the shot, return by 13 weeks, and use backup contraception if the dose is delayed beyond the recommended window.

Follow‑Up And Monitoring: arrange follow‑up to assess bleeding patterns, mood changes, weight, blood pressure, and bone health risk when considering long‑term injectable use.

• Emergency Checklist: know when to seek immediate care—signs of clot, severe abdominal pain, or signs of liver dysfunction.

Delivery Across United States